CEPI has signed agreements w/ Biofabri (Spain) & GC Pharma (Republic of Korea) to reserve vaccine manufacturing capacity for over 1 billion doses of CEPI-supported COVID-19 vaccines 🏭💉
. has reserved manufacturing capacity for 1 Billion #COVID19 vaccine doses. This will help the COVAX partnership with & produce & equitably deliver 2B doses of safe & effective vaccines by end-2021. #ACTogether